The funding will support further data curation and integration, an expanded database infrastructure, and enhanced data displays and query tools, among other things.
The panel distinguishes between patients with non-aggressive disease and more aggressive forms that could require interventions like radical prostatectomy.
The assay measures the levels of three metabolites in patient urine to detect adenomatous polyps, and is being offered as a laboratory-developed test by ADL.
